Telbivudine: A valuable treatment option in chronic hepatitis B

The last five years have emerged as a new era in the treatment of chronic hepatitis B (CHB). Advances in therapeutics and the approval of new drugs have been accompanied by a better understanding of the natural history and pathogenesis, as well as better diagnostics. In the treatment of CHB, no ther...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatitis B Annual 2011-01, Vol.8 (1), p.84-106
Hauptverfasser:	Singh, Shivaram, Lawate, Parimal
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Clinical trials Deoxyribonucleic acid DNA Hepatitis Hepatitis B Infections Interferon Liver diseases Medical prognosis Mortality Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!